[go: up one dir, main page]

MX2013000369A - Composiciones para el tratamiento de infecciones de pulmon, formuladas para ser administrables mediante aerolizacion, y que incluyen tobramicina. - Google Patents

Composiciones para el tratamiento de infecciones de pulmon, formuladas para ser administrables mediante aerolizacion, y que incluyen tobramicina.

Info

Publication number
MX2013000369A
MX2013000369A MX2013000369A MX2013000369A MX2013000369A MX 2013000369 A MX2013000369 A MX 2013000369A MX 2013000369 A MX2013000369 A MX 2013000369A MX 2013000369 A MX2013000369 A MX 2013000369A MX 2013000369 A MX2013000369 A MX 2013000369A
Authority
MX
Mexico
Prior art keywords
tobramycin
treatment
aerolisation
administration
lung infections
Prior art date
Application number
MX2013000369A
Other languages
English (en)
Other versions
MX336260B (es
Inventor
Thomas Norling
Original Assignee
Xellia Pharmaceuticals Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xellia Pharmaceuticals Aps filed Critical Xellia Pharmaceuticals Aps
Publication of MX2013000369A publication Critical patent/MX2013000369A/es
Publication of MX336260B publication Critical patent/MX336260B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención tiene que ver con una novedosa forma de administración y un nuevo régimen de administración útil en el tratamiento y prevención de infecciones bacterianas de pulmón en pacientes que lo requieren, en particular proveyendo una composición útil para la aerolización de una solución altamente concentrada de aminoglucósidos tales como la Tobramicina.
MX2013000369A 2010-07-12 2011-07-08 Composiciones para el tratamiento de infecciones de pulmon, formuladas para ser administrables mediante aerolizacion, y que incluyen tobramicina. MX336260B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36333010P 2010-07-12 2010-07-12
NO20101576 2010-11-08
PCT/EP2011/003405 WO2012007130A1 (en) 2010-07-12 2011-07-08 Treatment of lung infections by administration of tobramycin by aerolisation

Publications (2)

Publication Number Publication Date
MX2013000369A true MX2013000369A (es) 2013-02-15
MX336260B MX336260B (es) 2016-01-13

Family

ID=45439015

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013000369A MX336260B (es) 2010-07-12 2011-07-08 Composiciones para el tratamiento de infecciones de pulmon, formuladas para ser administrables mediante aerolizacion, y que incluyen tobramicina.

Country Status (12)

Country Link
US (2) US8598131B2 (es)
EP (1) EP2593110B1 (es)
JP (1) JP6000946B2 (es)
KR (1) KR102012418B1 (es)
CN (2) CN103052392A (es)
AU (1) AU2011278693B2 (es)
BR (1) BR112013000921A2 (es)
CA (1) CA2803187C (es)
ES (1) ES2855159T3 (es)
MX (1) MX336260B (es)
RU (1) RU2597842C2 (es)
WO (1) WO2012007130A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718189B2 (en) * 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
DK1581236T3 (da) * 2002-10-29 2013-12-02 Insmed Inc Opretholdt afgivelse af antiinfektionsmidler
ES2594368T3 (es) 2005-12-08 2016-12-19 Insmed Incorporated Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
EP2012750B1 (en) * 2006-04-06 2018-02-21 Insmed Incorporated Methods for coacervation induced liposomal encapsulation and formulations thereof
WO2008137717A1 (en) * 2007-05-04 2008-11-13 Transave, Inc. Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
US9114081B2 (en) * 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
JP6000946B2 (ja) 2010-07-12 2016-10-05 クセリア ファーマシューティカルズ エーピーエスＸｅｌｌｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ ＡｐＳ 肺感染症の治療のための組成物
WO2013177226A1 (en) 2012-05-21 2013-11-28 Insmed Incorporated Systems for treating pulmonary infections
AU2013352259B2 (en) 2012-11-29 2018-06-14 Insmed Incorporated Stabilized vancomycin formulations
KR102657132B1 (ko) 2014-05-15 2024-04-12 인스메드 인코포레이티드 폐의 비-결핵성 마이코박테리아 감염을 치료하기 위한 방법
WO2016065524A1 (zh) * 2014-10-27 2016-05-06 深圳市派友世纪电子商务有限公司 自动仓库控制系统及方法
CN105534961B (zh) * 2015-12-30 2019-06-04 孙红娟 妥布霉素吸入溶液及其制备方法
CN105616345B (zh) * 2016-03-01 2018-08-21 上海方予健康医药科技有限公司 一种妥布霉素吸入组合物及其制备方法和用途
JP7460534B2 (ja) 2018-03-30 2024-04-02 インスメッド インコーポレイテッド リポソーム医薬品の連続製造方法
US12075835B2 (en) 2018-09-24 2024-09-03 Imperial Tobacco Limited Aerosol delivery device with support for maintaining position of aerosol generator portion
GB201815463D0 (en) * 2018-09-24 2018-11-07 Nerudia Ltd Aerosol delivery device
WO2020163416A1 (en) * 2019-02-05 2020-08-13 Mylan Inc Devices and methods for tobramycin inhalation treatment
CN111228243B (zh) * 2019-12-24 2022-02-18 珠海亿胜生物制药有限公司 一种雾化吸入用妥布霉素脂质体及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9401260A (nl) 1993-11-12 1995-06-01 Cornelis Johannes Maria Van Ri Membraan voor microfiltratie, ultrafiltratie, gasscheiding en katalyse, werkwijze ter vervaardiging van een dergelijk membraan, mal ter vervaardiging van een dergelijk membraan, alsmede diverse scheidingssystemen omvattende een dergelijk membraan.
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
US5855564A (en) * 1997-08-20 1999-01-05 Aradigm Corporation Aerosol extrusion mechanism
US20020017295A1 (en) * 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
EP1161247A4 (en) * 1998-12-17 2002-05-15 Chiron Corp Treatment method for severe chronic bronchitis (bronchiectasis) using an antibiotic aerosol
AU3500901A (en) * 2000-02-11 2001-08-20 Medic Aid Ltd Drug delivery apparatus
NL1016030C1 (nl) 2000-08-28 2002-03-01 Aquamarijn Holding B V Sproei inrichting met een nozzleplaat, een nozzleplaat, alsmede werkwijzen ter vervaardiging en voor toepassing van een dergelijke nozzleplaat.
EP1598059A1 (en) * 2001-05-18 2005-11-23 Chiron Corporation Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
DE60210402T2 (de) * 2001-05-18 2006-12-07 Chiron Corp., Emeryville System zur Abgabe einer Tobramycin-Formulierung
TR200401980T4 (tr) 2001-07-02 2004-09-21 Chiesi Farmaceutici S.P.A. Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu
JP2003221335A (ja) * 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
EP1458360B1 (en) * 2001-12-19 2011-05-11 Novartis AG Pulmonary delivery of aminoglycosides
EP1321159A1 (en) * 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP1673074B1 (de) * 2003-10-15 2007-01-03 PARI GmbH Spezialisten für effektive Inhalation Flüssige zubereitung enthaltend tobramycin
RS55114B1 (sr) * 2005-05-18 2016-12-30 Raptor Pharmaceuticals Inc Aerosolizovani fluorohinoloni i njihove upotrebe
KR101424518B1 (ko) * 2005-09-29 2014-08-06 노바르티스 아게 항생제 제형, 단위 투여체, 키트 및 방법
LT1991201T (lt) * 2006-02-10 2018-07-25 Pari Pharma Gmbh Puškiami antibiotikai inhaliaciniam gydymui
EP2485793B1 (en) 2009-10-08 2016-10-26 SHL Group AB Metered liquid droplet inhaler
JP6000946B2 (ja) 2010-07-12 2016-10-05 クセリア ファーマシューティカルズ エーピーエスＸｅｌｌｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ ＡｐＳ 肺感染症の治療のための組成物

Also Published As

Publication number Publication date
US9067032B2 (en) 2015-06-30
MX336260B (es) 2016-01-13
ES2855159T3 (es) 2021-09-23
US20120010162A1 (en) 2012-01-12
KR102012418B1 (ko) 2019-08-20
CN106074461A (zh) 2016-11-09
AU2011278693A1 (en) 2013-01-24
RU2013103534A (ru) 2014-08-20
WO2012007130A1 (en) 2012-01-19
RU2597842C2 (ru) 2016-09-20
JP2013530248A (ja) 2013-07-25
KR20130130689A (ko) 2013-12-02
CA2803187C (en) 2019-05-14
CN103052392A (zh) 2013-04-17
BR112013000921A2 (pt) 2016-05-17
EP2593110A1 (en) 2013-05-22
ES2855159T8 (es) 2022-01-04
AU2011278693B2 (en) 2015-02-19
US8598131B2 (en) 2013-12-03
EP2593110B1 (en) 2021-01-06
US20140041654A1 (en) 2014-02-13
JP6000946B2 (ja) 2016-10-05
CA2803187A1 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
MX2013000369A (es) Composiciones para el tratamiento de infecciones de pulmon, formuladas para ser administrables mediante aerolizacion, y que incluyen tobramicina.
NZ602544A (en) Crystalline forms of a macrolide, and uses therefor
PH12012501841B1 (en) Anti-infective compounds
MX2019009132A (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
NZ708928A (en) Mannose derivatives for treating bacterial infections
GEP20156370B (en) Fluoro-pyridinone derivatives useful as antibacterial agents
MX349827B (es) Compuestos que contienen nitrogeno y su uso.
MY198204A (en) Cyclic Boronic Acid Ester Derivatives And Therapeutic Uses Thereof
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
HK1218836A1 (zh) 协同细菌组合物和其制造方法和用途
MX2018001075A (es) Agentes terapeuticos y profilacticos antibacterianos.
MX364942B (es) Peptidos antimicrobianos.
MX352760B (es) Metodos para tratar infecciones intrapulmonares.
MX2011006803A (es) Agentes antibacterianos novedosos para el tratamiento de infecciones gram positivas.
MX2012000136A (es) Composiciones que comprenden finafloxacina y metodos para tratar infecciones oftalmicas, oticas, o nasales.
SG10201900541QA (en) Derivatives of xanthone compounds
WO2014022382A3 (en) Antibacterial protein kinase inhibitors
MX2016007626A (es) Peptido antimicrobiano y usos del mismo.
PH12018500358A1 (en) Compounds for use in an antibacterial applications
MX382439B (es) Compuestos de carbapenem
MX337145B (es) Composiciones farmaceuticas.
PH12015501428A1 (en) Antibacterial compounds
PH12013501069A1 (en) Pharmaceutical compositions
HK1241754A1 (en) Pulmonary administration of pyocins for treating bacterial respiratory infections
HK1229697A1 (en) Synergistic bacterial compositions and methods of production and use thereof